Evidence map›Paper›PMID 38310116›Full record

ArticleScientific reports2024

Ultra-restrictive red blood cell transfusion strategies in extensively burned patients.

Yiran Wang, Zhikang Zhu, Deqing Duan, Wanting Xu, Zexin Chen, Tao Shen, Xingang Wang, Qinglian Xu, Hongyan Zhang, Chunmao Han

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. The effect of allogeneic blood transfusion on burn mortality in a resource-limited setting.Burns : journal of the International Society for Burn Injuries · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Yiran Wang *Department of Burns & Wound Care Center, The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, 310009, China.
Zhikang Zhu *Department of Burns & Wound Care Center, The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, 310009, China.
Deqing DuanDepartment of Burns, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Wanting XuDepartment of Burn Injury, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zexin ChenCenter of Clinical Epidemiology & Biostatistics, Department of Scientific Research, The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China.
Tao ShenDepartment of Burns & Wound Care Center, The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, 310009, China.
Xingang WangDepartment of Burns & Wound Care Center, The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, 310009, China. wangxingang8157@zju.edu.cn.
Qinglian XuDepartment of Burn Injury, The First Affiliated Hospital of Anhui Medical University, Hefei, China. xuqinglian@sina.com.
Hongyan ZhangDepartment of Burns, The First Affiliated Hospital of Nanchang University, Nanchang, China. ndyfy00672@ncu.edu.cn.
Chunmao HanDepartment of Burns & Wound Care Center, The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, 310009, China. zrssk@zju.edu.cn.
Second Affiliated Hospital of Zhejiang University · CNFirst Affiliated Hospital of Anhui Medical University · CNFirst Affiliated Hospital of Nanchang University · CNKey Laboratory of Guangdong Province · CNNanchang University · CN

Funding

National key research and development project 2022YFC2403100National Natural Science Foundation of China 81772069Natural Science Foundation of Zhejiang province LGF20H150004Natural Science Foundation of Zhejiang province LQ19H040015
6 · The paper itself

Abstract

In recent years, due to the shortage of blood products, some extensive burn patients were forced to adopt an "ultra-restrictive" transfusion strategy, in which the hemoglobin levels of RBC transfusion thresholds were < 7 g/dl or even < 6 g/dl. This study investigated the prognostic impacts of ultra-restrictive RBC transfusion in extensive burn patients. This retrospective multicenter cohort study recruited extensive burns (total body surface area ≥ 50%) from three hospitals in Eastern China between 1 January 2016 and 30 June 2022. Patients were divided into an ultra-restrictive transfusion group and a restrictive transfusion group depending on whether they received timely RBC transfusion at a hemoglobin level < 7 g/dl. 1:1 ratio propensity score matching (PSM) was performed to balance selection bias. Modified Poisson regression and linear regression were conducted for sensitive analysis. Subsequently, according to whether they received timely RBC transfusion at a hemoglobin level < 6 g/dl, patients in the ultra-restrictive transfusion group were divided into < 6 g/dl group and 6-7 g/dl group to further compare the prognostic outcomes. 271 eligible patients with extensive burns were included, of whom 107 patients were in the ultra-restrictive transfusion group and 164 patients were in the restrictive transfusion group. The ultra-restrictive transfusion group had a significantly lower RBC transfusion volume than the restrictive transfusion group (11.5 [5.5, 21.5] vs 17.3 [9.0, 32.5] units, p = 0.004). There were no significant differences between the two groups in terms of in-hospital mortality, risk of infection, hospital length of stay, and wound healing time after PSM or multivariate adjustment (p > 0.05). Among the ultra-restrictive transfusion group, patients with RBC transfusion threshold < 6 g/dl had a significantly higher hospital mortality than 6-7 g/dl (53.1% vs 21.3%, p = 0.001). For extensive burn patients, no significant adverse effects of ultra-restrictive RBC transfusion were found in this study. When the blood supply is tight, it is acceptable to adopt an RBC transfusion threshold of < 7 g/dL but not < 6 g/dL.

Indexed as

BurnsErythrocyte TransfusionBlood TransfusionCohort StudiesHemoglobinsHumansHemoglobins

Identifiers

PMID38310116
PMCPMC10838330
OpenAlexW4391514937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.